Stockscreener 앱 받기
0.3167
24.05%
0.0614
시간 외 거래:
.32
0.0033
+1.04%
전일 마감가:
$0.2553
열려 있는:
$0.31
하루 거래량:
85.24M
Relative Volume:
15.66
시가총액:
$32.30M
수익:
$36.12M
순이익/손실:
$-232.49M
주가수익비율:
-0.0178
EPS:
-17.78
순현금흐름:
$-126.87M
1주 성능:
+50.81%
1개월 성능:
+33.63%
6개월 성능:
-44.52%
1년 성능:
-82.88%
1일 변동 폭
$0.2766
$0.38
1주일 범위
$0.2051
$0.38
52주 변동 폭
$0.194
$1.90
바이오나노 지노믹스 Stock (BNGO) Company Profile
명칭
Bionano Genomics Inc
전화
(858) 888-7600
주소
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
BNGO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
0.3167 | 32.30M | 36.12M | -232.49M | -126.87M | -17.78 |
|
ISRG
Intuitive Surgical Inc
|
535.29 | 190.66B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
228.46 | 66.26B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
84.06 | 41.58B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
231.67 | 34.01B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
335.56 | 24.30B | 2.88B | 499.60M | 321.60M | 6.74 |
바이오나노 지노믹스 Stock (BNGO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-15 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2024-09-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-12-12 | 재개 | BTIG Research | Buy |
| 2022-07-18 | 재개 | Oppenheimer | Outperform |
| 2021-06-16 | 개시 | BTIG Research | Buy |
| 2020-09-24 | 개시 | Ladenburg Thalmann | Buy |
| 2020-04-08 | 개시 | Oppenheimer | Outperform |
모두보기
바이오나노 지노믹스 주식(BNGO)의 최신 뉴스
Bionano stock rallies 19% on ATM direct offering - MSN
Bionano Genomics Announces Registered Direct Stock Offering to Raise $10 Million - Marketscreener.com
Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - The Manila Times
Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - GlobeNewswire Inc.
BNGO (Bionano Genomics) Earnings per Share (Diluted) : $-4.46 (TTM As of Sep. 2024) - GuruFocus.com
S&P 500 Growth (IGX) QuotePress Release - The Globe and Mail
Nasdaq Biotechnology Index (NBI) QuotePress Release - The Globe and Mail
TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail
Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway - The Manila Times
Bayer Aktienges ADR (BAYRY) QuotePress Release - The Globe and Mail
Pfizer Inc (PFE-N) QuotePress Release - The Globe and Mail
Senior Loan Invesco ETF (BKLN-A) QuotePress Release - The Globe and Mail
Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis - The Manila Times
Bionano's Groundbreaking Study: Optical Genome Mapping Achieves 100% Detection Rate in Cancer Analysis - StockTitan
UK Natural Gas (NFJ22) Quote - The Globe and Mail
Bionano Genomics stock hits 52-week low at $0.2 amid market challenges - Investing.com India
Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal - The Manila Times
Bionano Genomics Issues Critical Stockholder Letter Ahead of Special Meeting - StockTitan
Bionano Genomics, Inc. (NASDAQ:BNGO) Might Not Be As Mispriced As It Looks - Simply Wall St
Uber Technologies Inc (UBER-N) QuotePress Release - The Globe and Mail
Bionano Genomics announces presentations at ASH annual meeting - Nasdaq
Bionano Announces Presentations at the American Society of Hematology (ASH) Annual Meeting that Underscore OGM Utility Across Blood Cancer Research and Cell & Gene Therapy - The Manila Times
Bionano Genomics Showcases Breakthrough OGM Technology Across 13 Cancer Research Studies at ASH 2024 - StockTitan
Tractor Supply Company (TSCO-Q) QuotePress Release - The Globe and Mail
Bionano Genomics (STU:2Y30) Current Ratio : 1.43 (As of Sep. 2024) - GuruFocus.com
Bionano Genomics shareholders approve warrant share issuance By Investing.com - Investing.com Nigeria
Bionano Genomics shareholders approve warrant share issuance - Investing.com
Bionano Genomics (LTS:0A4K) Enterprise Value : $25.57 Mil (As of Dec. 01, 2024) - GuruFocus.com
Bionano Genomics (LTS:0A4K) Degree of Operating Leverage : 51.41 (As of Sep. 2024) - GuruFocus.com
Bionano Genomics (FRA:2Y30) Current Ratio : 1.43 (As of Sep. 2024) - GuruFocus.com
Bionano Genomics stock hits 52-week low at $0.2 By Investing.com - Investing.com Australia
Bionano Genomics stock hits 52-week low at $0.2 - Investing.com
BNGO (Bionano Genomics) Accumulated other comprehensive inc - GuruFocus.com
BNGO (Bionano Genomics) 50-Day SMA : $0.35 (As of Nov. 20, 2024) - GuruFocus.com
BNGO (Bionano Genomics) 6-Month Price Index : 0.20 (As of Nov. 20, 2024) - GuruFocus.com
Bionano Genomics (FRA:2Y30) Operating Margin % : -372.57% (As of Sep. 2024) - GuruFocus.com
BTIG maintains neutral on BNGO shares amid Q3 results and strategy shift - Investing.com
Bionano Genomics, Inc. (NASDAQ:BNGO) Q3 2024 Earnings Call Transcript - Insider Monkey
Bionano Genomics Inc (BNGO) Quarterly 10-Q Report - Quartzy
Bionano Genomics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Bionano Genomics stock hits 52-week low at $0.26 By Investing.com - Investing.com Australia
Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress - The Manila Times
Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: St - GuruFocus.com
Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... By GuruFocus - Investing.com Canada
Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... - Yahoo Finance
Optical Genome Mapping Market Size, Share, Trends, - openPR
Bionano Genomics Sees Growth in OGM Adoption - TipRanks
Earnings call: Bionano reports Q3 revenue dip, shifts focus to efficiency - Investing.com Canada
Bionano Genomics (BNGO) Q3 2024 Earnings Call Transcript - MSN
Bionano Genomics Q3 Revenue Falls 35% Despite OGM System Growth; Reports Mixed Results | BNGO Stock News - StockTitan
Bionano Genomics stock hits 52-week low at $0.26 - Investing.com
바이오나노 지노믹스 (BNGO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.64%
0.11%
자본화:
|
볼륨(24시간):